Surrozen (SRZN) Shareholder's Equity (2020 - 2026)
Surrozen (SRZN) Shareholder's Equity (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
502.95 Mn |
| 10 |
Surrozen |
225,877.86 |
-106.68 Mn |
- |
-278.15 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-278.15 Mn |
| Dec 31, 2025 |
-187.76 Mn |
| Sep 30, 2025 |
-23.52 Mn |
| Jun 30, 2025 |
47.11 Mn |
| Mar 31, 2025 |
5.67 Mn |
| Dec 31, 2024 |
-21.38 Mn |
| Sep 30, 2024 |
5.67 Mn |
| Jun 30, 2024 |
6.06 Mn |
| Mar 31, 2024 |
30.14 Mn |
| Dec 31, 2023 |
37.94 Mn |
| Sep 30, 2023 |
45.53 Mn |
| Jun 30, 2023 |
55.06 Mn |
| Mar 31, 2023 |
63.04 Mn |
| Dec 31, 2022 |
76.00 Mn |
| Sep 30, 2022 |
77.49 Mn |
| Jun 30, 2022 |
89.70 Mn |
| Mar 31, 2022 |
102.66 Mn |
| Dec 31, 2021 |
109.70 Mn |
| Sep 30, 2021 |
123.73 Mn |
| Jun 30, 2021 |
22.82 Mn |
